M
Myla E. Moretti
Researcher at Hospital for Sick Children
Publications - 8
Citations - 203
Myla E. Moretti is an academic researcher from Hospital for Sick Children. The author has contributed to research in topics: Pregnancy & Expected value of perfect information. The author has an hindex of 7, co-authored 8 publications receiving 186 citations.
Papers
More filters
Journal ArticleDOI
Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis.
TL;DR: A random-effects meta-analysis model was used to combine the risk data from 1402 studies that reported the incidence of hypospadias or other congenital malformations in offspring of women who did or did not use loratadine during pregnancy.
Journal ArticleDOI
Effect of Domperidone on Insufficient Lactation in Puerperal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
TL;DR: Evidence from a few small RCTs of moderate to high quality suggests that domperidone produces a greater increase in breast milk supply than placebo.
Journal Article
Which drugs are contraindicated during breastfeeding? Practice guidelines.
TL;DR: Only a few drugs pose a clinically significant risk to breastfed babies, and in general, antineoplastics, drugs of abuse, some anticonvulsants, ergot alkaloids, and radiopharmaceuticals should not be taken, and levels of amiodarone, cyclosporine, and lithium should be monitored.
Journal ArticleDOI
Drugs during Pregnancy and Lactation, 2nd edition
Journal ArticleDOI
Genetic testing in combination with preventive donepezil treatment for patients with amnestic mild cognitive impairment: an exploratory economic evaluation of personalized medicine.
S. Djalalov,S. Djalalov,Jean Yong,Jean Yong,Jaclyn Beca,Jaclyn Beca,Sandra E. Black,Sandra E. Black,Gustavo Saposnik,Gustavo Saposnik,Zahra Musa,Katherine A. Siminovitch,Katherine A. Siminovitch,Myla E. Moretti,Jeffrey S Hoch,Jeffrey S Hoch,Jeffrey S Hoch +16 more
TL;DR: This exploratory study illustrates that genetic testing combined with preventive donepezil treatment for AMCI patients may be economically attractive and is insufficient to warrant recommending APOE genotyping in AM CI patients.